Perdagangan Bebas Produk Farmasi dan Alat Kesehatan serta Kesiapan Memenuhi Persyaratan Cetak Biru Masyarakat Ekonomi ASEAN

  • Lukman Prayitno Pusat Penelitian dan Pengembangan Humaniora dan Manajemen Kesehatan, Kemenkes RI, Jakarta, Indonesia
  • Max Joseph Herman Pusat Penelitian dan Pengembangan Sumber Daya dan Pelayanan Kesehatan, Jakarta
Keywords: ASEAN Economic Community, Free trade in goods, Pharmaceutical products and medical devices, AEC blueprint

Abstract

The implementation of the ASEAN Economic Community (AEC) as an Indonesian Government’s strategic step has an impact on economic globalization. The study on pharmaceutical products and medical devices free trade was done using qualitative and quantitative methods. The data were collected from a round table discussion about "Free Trade in Health Goods and Services in ASEAN" which involved the Ministry of Health (MoH), Ministry of Trade (MoT), and National Agency for Drug and Food Control (NADFC). The discussion aimed to obtain information on the readiness to meet the AEC blueprint. Secondary data on export and import of pharmaceutical products and medical devices were obtained from the MoT. The results of the study show that between 2013 and 2017 there were 70-72 product items exported to 9 ASEAN countries with a value much greater than the import. The tariff measure (TM) requirements included the Most Favored Nation (MFN) assessment and regulation of the trade remedy procedure by MoH and MoT. The implementation of ASEAN Common Technical Dossier (ACTD) and Good Manufacturing Practice inspection agreements, Bioequivalence reporting agreements, agreements related to traditional medicines and health supplement have been done by NADFC and industry. The simplification of Certificate of Origin, operation certification procedures and realization of ASEAN self-certification have to be specified. MoH must coordinate with NADFC and MoT in deciding and implementing regulations

References

The ASEAN Secretariat. ASEAN economic community blueprint 2025 [internet]. Jakarta: The ASEAN Secretariat; 2015 Nov [cited 2019 Mar]. Available from: https://www.asean.org/storage/2016/03/AECBP_2025r_FINAL.pdf

The ASEAN Secretariat. ASEAN trade in goods agreement [internet]. Cha-am: The ASEAN Secretariat; 2009 Feb 26 [cited 2019 Mar 3]. Available from: https://www.asean. org/wpcontent/uploads/images/2012/Economic/AFTA/annex/ASEAN%20Trade%20in%20Goods%20Agreement,%20Chaam,%20Thailand,%2026%20February%202009.pdf

Republik Indonesia. Peraturan Menteri Kesehatan Nomor 17 Tahun 2017 tentang Rencana Aksi Pengembangan Industri Farmasi dan Alat Kesehatan, Jakarta: Kementerian Kesehatan; 2017.

Ardiyani, Ginting B, Nugraheni T, Sahara N, Yolandra R, et al, Upaya Kemandirian Produksi Bahan Baku Obat Indonesia. Buletin Infarkes. Edisi II Maret - April 2016 http://binfar.kemkes.go.id/?wpdmact=process&did=MzU1LmhvdGxpbms=[disitasi Mei 2019], 802, 3–6.

Primadi O. Jumlah Alat Kesehatan Produksi Dalam Negeri Meningkat, http://sehatnegeriku.kemkes.go.id/baca/rilismedia/20171109/1723731/jumlah-alat-kesehatan-produksi-negeri-meningkat/ [disitasi 10 Febr 2019]

Yufani E, Harto S. Implikasi ASEAN economic community blueprint terhadap perkembangan perdagangan Indonesia ke Singapura. Jurnal Online Mahasiswa Bidang Ilmu Sosial dan Ilmu Politik [internet]. 2014 Jun 17 [disitasi 2019 Feb];1(1):1-15.

Arianti RK, Hasni H. Kinerja perdagangan serta strategi ekspor produk-produk pharmaceutical dan kosmetik berbasis herbal Indonesia di pasar dunia. Buletin Ilmiah Litbang Perdagangan. 2010 Jul 31;4(1):14-30. https://doi.org/10.30908/bilp.v4i1.149

Eeyore. Unggul di produksi obat, kalah di tenaga kerja ahli [internet]. Jakarta: Utama Consulting Business & Tax Advisory; 2016 Jan 15 [disitasi 10 Febr 2019]. Diunduh dari: https://pemeriksaanpajak.com/2016/01/15/unggul-di-produksi-obat-kalah-di-tenaga-kerja-ahli/

Khamdi M. MEA 2015: Farmasi Indonesia bersaing ketat dengan Vietnam. Berita Online Ekonomi Bisnis.com [internet]. 2014 Apr 17 [disitasi 2019 Feb 10]. Diunduh dari: https://ekonomi.bisnis.com/read/20140417/103/220100/mea-2015-farmasi-indonesia-bersaing-ketat-dengan-vietnam

Sari TIP, Hidayat K, Setyawan A. Pengaruh bea masuk dan pajak dalam rangka impor (BM dan PDRI) terhadap total penerimaan. Jurnal Perpajakan (JEJAK). 2016;10(1):1-8.

Alhayat AP. Efektivitas tindakan anti dumping Indonesia 1996-2010. Buletin Ilmiah Litbang Perdagangan. 2014 Des 31;8(2):247-68. DOI: https://doi.org/10.30908/bilp.v8i2.95

Dinasari D, Widhiyanti HN, Ikaningtyas I. Kesesuaian aturan multilateral agreement on trade in goods WTO Dengan ATIGA (ASEAN trade in goods agreement). Jurnal Hukum [internet]. 2014 April:1-21.

Saragih HM. Indonesia dan persaingan di era ASEAN economic community. Jurnal Masharif Al-Syariah: Jurnal Ekonomi dan Perbankan Syariah. 2017;2(2):117-152. DOI: http://dx.doi.org/10.30651/jms.v2i2.1445

Darmawan A, Irawan R. Mengenal CPOB untuk produk darah. Jambi Medical Journal: Jurnal Kedokteran dan Kesehatan. 2015 Nov;3(2):111-18. DOI: https://doi.org/10.22437/jmj.v3i2.3087

Rachmawati E, Holidah D. Uji bioavailabilitas dan bioekuivalensi obat: urgensi dan pedoman pelaksanaannya. Saintifika. 2011 Jun;13(l):91-7.

Published
2020-02-24
How to Cite
1.
Prayitno L, Herman M. Perdagangan Bebas Produk Farmasi dan Alat Kesehatan serta Kesiapan Memenuhi Persyaratan Cetak Biru Masyarakat Ekonomi ASEAN. jki [Internet]. 24Feb.2020 [cited 14Jul.2020];10(1):67-8. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/1966